OsiriX MD vs Weasis:Which is more popular?
In September 2026, Weasis had more branded searches than OsiriX MD among medical imaging software worldwide. Weasis had about 9,900 branded searches, while OsiriX MD had 6,120. Weasis made up 0.84% of all medical imaging software searches we track, and OsiriX MD accounted for 0.52%. When we asked ChatGPT and Google AI Overviews about medical imaging software, OsiriX MD and Weasis each appeared in three of the five answers. Weasis was mentioned before OsiriX MD in three out of four answers that named either.
Who do people search for more?
Weasis, about 62% more searches than OsiriX MD
Who does AI mention more?
Both were mentioned in 3 of 5 answers.
Who does AI recommend more?
Weasis, named ahead of OsiriX MD in 3 of 4 answers
Follow OsiriX MD vs Weasis and get free monthly updates on what changed
By continuing you'll get index updates and occasional product news from Brandwave. Unsubscribe any time. Privacy
Top medical imaging software in ChatGPT and Google AI Overviews
In three ChatGPT questions and two Google AI Overviews, OsiriX MD was mentioned in three out of five: in one of the three ChatGPT answers and in both Google AI Overviews. Weasis was mentioned in three out of five: in two of the three ChatGPT answers and in one of the two Google AI Overviews. Weasis was listed before OsiriX MD in three out of four answers that named either.
Most recommended by AI
Brands get a higher ranking if they are mentioned earlier in the answers.
- Weasis1st
3D Slicer2nd
RadiAnt DICOM Viewer3rd
Horos4th
OsiriX MD5th
OHIF Viewer6th
Sectra7th
Philips8th
GE HealthCare9th
Fujifilm–- +1 more
Mentioned by AI
Each dot is one answer, filled in when that answer mentions the brand.
- 3D Slicer4 of 5Named in 3 of 3 ChatGPT answersNamed in 1 of 2 Google answers
- RadiAnt DICOM Viewer4 of 5Named in 3 of 3 ChatGPT answersNamed in 1 of 2 Google answers
- Weasis3 of 5Named in 2 of 3 ChatGPT answersNamed in 1 of 2 Google answers
- OsiriX MD3 of 5Named in 1 of 3 ChatGPT answersNamed in 2 of 2 Google answers
- OHIF Viewer3 of 5Named in 3 of 3 ChatGPT answersNamed in 0 of 2 Google answers
- Horos3 of 5Named in 1 of 3 ChatGPT answersNamed in 2 of 2 Google answers
- GE HealthCare1 of 5Named in 1 of 3 ChatGPT answersNamed in 0 of 2 Google answers
- Philips1 of 5Named in 1 of 3 ChatGPT answersNamed in 0 of 2 Google answers
- Sectra1 of 5Named in 1 of 3 ChatGPT answersNamed in 0 of 2 Google answers
- Fujifilm0 of 5Named in 0 of 3 ChatGPT answersNamed in 0 of 2 Google answers
See every answer about medical imaging software
5 answers
Asked ChatGPT
“Which medical imaging software should I use?”
Asked ChatGPT
“What are the best medical imaging software options?”
Asked ChatGPT
“What's the best medical imaging software for medical image viewing?”
Searched Google, AI Overview
“dicom viewer software”
Searched Google, AI Overview
“medical imaging software”
Not named in any answer:
Brands are shown in the order each answer named them. The survey took place in the United States on October 21, 2026.
Is OsiriX MD or Weasis more popular in search?
This chart shows how often people search Google for OsiriX MD and Weasis by name. Each line represents a brand's share of searches for all 11 medical imaging software we track, month by month, from English-language searches worldwide.
Share of searches by month for Weasis, OsiriX MD. The figures are in the table below the chart.
View monthly share of searches table
| Month | Fujifilm | GE HealthCare | Philips | 3D Slicer | RadiAnt DICOM Viewer | Sectra | Weasis | OsiriX MD | Agfa HealthCare | OHIF Viewer | Horos |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2025 | 63.6% | 10.4% | 19% | 2.1% | 1.7% | 1.1% | 0.63% | 0.7% | 0.34% | 0.19% | 0.15% |
| Nov 2025 | 62.3% | 8.3% | 22.8% | 2.1% | 1.6% | 1.1% | 0.61% | 0.57% | 0.27% | 0.22% | 0.14% |
| Dec 2025 | 67% | 7.4% | 20.2% | 1.8% | 1.5% | 0.81% | 0.44% | 0.49% | 0.19% | 0.16% | 0.11% |
| Jan 2026 | 67.7% | 9.1% | 16.7% | 1.8% | 2.1% | 0.82% | 0.55% | 0.61% | 0.24% | 0.2% | 0.13% |
| Feb 2026 | 62.6% | 10.2% | 18.7% | 2.5% | 2.4% | 1.4% | 0.75% | 0.7% | 0.33% | 0.27% | 0.18% |
| Mar 2026 | 67.1% | 11% | 13.5% | 2.7% | 2.5% | 1.2% | 0.66% | 0.61% | 0.29% | 0.29% | 0.15% |
| Apr 2026 | 67.2% | 11% | 13.5% | 2.7% | 2.5% | 1.2% | 0.66% | 0.61% | 0.29% | 0.24% | 0.16% |
| May 2026 | 70.8% | 9.5% | 11.6% | 2.8% | 2.2% | 1% | 0.7% | 0.64% | 0.31% | 0.25% | 0.16% |
| Jun 2026 | 67.1% | 11% | 13.5% | 2.7% | 2.1% | 1.5% | 0.81% | 0.61% | 0.36% | 0.29% | 0.16% |
| Jul 2026 | 72.9% | 9.7% | 9.7% | 2.4% | 2.2% | 1.1% | 0.72% | 0.53% | 0.32% | 0.26% | 0.14% |
| Aug 2026 | 70.8% | 9.5% | 11.6% | 2.3% | 2.6% | 1% | 0.85% | 0.52% | 0.31% | 0.25% | 0.14% |
| Sep 2026 | 69.5% | 11.4% | 11.4% | 2.3% | 2.1% | 1.2% | 0.84% | 0.52% | 0.3% | 0.24% | 0.16% |
How has the OsiriX MD and Weasis comparison changed over the last 12 months?
3 findings
- The lead changed hands 3 times in the 12 months ending September 2026: Weasis took it in November 2025, OsiriX MD took it in December 2025, Weasis took it in February 2026.
- Across the 12 months ending September 2026, OsiriX MD’s share of searches among medical imaging software worldwide moved from 0.7% to 0.52%, and its estimated monthly branded searches moved from 9.1K to 6.1K.
- Across the 12 months ending September 2026, Weasis’ share of searches among medical imaging software worldwide moved from 0.63% to 0.84%, and its estimated monthly branded searches moved from 8.1K to 9.9K.
How did search popularity change for medical imaging software worldwide in September 2026?
2 changes
How are branded searches counted?
3 search terms
Brandwave collects information about searches that people make online using OsiriX MD’s and Weasis’ names. When viewed over time, estimated search volumes for these branded terms can be used to understand whether interest in the brands is growing, holding steady, or fading.
Other head-to-heads among medical imaging software
Put your own brand in this comparison
Brandwave tracks your branded demand next to the rival you actually watch, with your campaigns, spend and outcomes on the same timeline.